• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Suven Life Sciences Limited — Updates, 12-06-2026: Press Release

    12-06-2026 | 11:23 am

    Suven Life Sciences presents three posters on Samelisant (SUVN-G3031) at SLEEP-2026. These showcase positive Phase 2 data for narcolepsy's excessive daytime sleepiness and outline the Phase 3 development strategy, marking significant clinical advancement.

    No comments yet. Be the first to comment!

    All announcements from Suven Life Sciences Limited